Horizon Therapeutics plc Announces Teprotumumab Expanded Access Program
DUBLIN–(BUSINESS WIRE)–Horizon Therapeutics plc (Nasdaq: HZNP) today announced the availability of an expanded access program for its investigational medicine teprotumumab.…
Pharmaceuticals, Biotechnology and Life Sciences
DUBLIN–(BUSINESS WIRE)–Horizon Therapeutics plc (Nasdaq: HZNP) today announced the availability of an expanded access program for its investigational medicine teprotumumab.…
NEW YORK–(BUSINESS WIRE)–#analytics–PharmaVOICE has named Asaf Evenhaim, the CEO and co-founder of Crossix, as one of its PharmaVOICE 100 for…
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Tricida, Inc. (Nasdaq: TCDA), a pharmaceutical company focused on the development and commercialization of its drug…
DUBLIN–(BUSINESS WIRE)–The “Cancer Immunotherapy Market Analysis By Product (Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies, Cancer Vaccines), By Cancer Type, And…
NEWPORT BEACH, SAN DIEGO & SAN FRANCISCO, Calif.–(BUSINESS WIRE)–#BIO–On Tuesday, August 13, California Life Sciences Association (CLSA), the trade association…
LONDON–(BUSINESS WIRE)–#Biotechnology–The global gynecological cancers therapeutics market is expected to grow by USD 8.96 billion during the period 2019- 2023,…
DUBLIN–(BUSINESS WIRE)–The “Nitric Oxide – Therapeutics, Markets and Companies” report from Jain PharmaBiotech has been added to ResearchAndMarkets.com’s offering. This…
DUBLIN–(BUSINESS WIRE)–The “Pain Therapeutics – Drugs, Markets and Companies” report from Jain PharmaBiotech has been added to ResearchAndMarkets.com’s offering. This…
CANTON, Mich. & FRISCO, Texas–(BUSINESS WIRE)–#DIA2019–MMS Holdings – an award-winning, data-focused CRO – announced that today marks 10 years of…
MANCHESTER, England–(BUSINESS WIRE)–2e Creative, an internationally recognised healthcare marketing strategy firm focused on launching pharmaceutical and medical device products, has…